• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过高压液相色谱法和沙门氏菌/微粒体试验检测致癌物和非致癌物中的致突变杂质。

Detection of mutagenic impurities in carcinogens and noncarcinogens by high-pressure liquid chromatography and the Salmonella/microsome test.

作者信息

Donahue E V, McCann J, Ames B N

出版信息

Cancer Res. 1978 Feb;38(2):431-8.

PMID:340030
Abstract

We have used high-pressure liquid chromatography and the Salmonella/microsome mutagenicity test to look for mutagenic impurities in 11 carcinogens and noncarcinogens. Because of the million-fold range in mutagenic potency observed in the Salmonella test, even trace amounts of potent mutagenic impurities in a nonmutagenic compound could be detected. The mutagenicity of 7-hydroxy-2-acetylaminofluorene, a noncarcinogen in the standard animal carcinogenicity tests, is shown to be due to a small amount of impurity, which is probably the potent carcinogen 2-acetylaminofluorene. This is discussed in relation to the statistical limitations of animal carcinogenicity tests. We also discuss the role of mitogenic impurities in assessing the mutagenicity of environmental (and industrial) chemicals with high-sensitivity mutagenicity assays, such as the Salmonella/microsome test.

摘要

我们运用高压液相色谱法和沙门氏菌/微粒体诱变性试验,来探寻11种致癌物和非致癌物中的致突变杂质。鉴于在沙门氏菌试验中观察到诱变性效力存在百万倍的差异,即便非诱变化合物中存在痕量的强效诱变杂质也能够被检测出来。在标准动物致癌性试验中为非致癌物的7-羟基-2-乙酰氨基芴的诱变性,被证明是由少量杂质所致,该杂质可能是强效致癌物2-乙酰氨基芴。结合动物致癌性试验的统计学局限性对此进行了讨论。我们还讨论了促有丝分裂杂质在通过高灵敏度诱变性测定法(如沙门氏菌/微粒体试验)评估环境(和工业)化学品诱变性中的作用。

相似文献

1
Detection of mutagenic impurities in carcinogens and noncarcinogens by high-pressure liquid chromatography and the Salmonella/microsome test.通过高压液相色谱法和沙门氏菌/微粒体试验检测致癌物和非致癌物中的致突变杂质。
Cancer Res. 1978 Feb;38(2):431-8.
2
Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.BALB/c - 3T3细胞的转化:V. 168种化学物质的转化反应与沙门氏菌致突变性及啮齿动物生物测定致癌性的比较
Environ Health Perspect. 1993 Jul;101 Suppl 2(Suppl 2):347-482. doi: 10.1289/ehp.93101s2347.
3
Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test.
Cancer Res. 1977 Jul;37(7 Pt 1):2209-13.
4
Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.在沙门氏菌/微粒体试验中作为诱变剂的致癌物检测:300种化学物质的测定
Proc Natl Acad Sci U S A. 1975 Dec;72(12):5135-9. doi: 10.1073/pnas.72.12.5135.
5
Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.大鼠肝细胞介导的细菌诱变性与苯并(a)蒽、苯并(a)芘及25种甲基化衍生物的致癌潜能的关系。
Cancer Res. 1987 Mar 15;47(6):1509-15.
6
L-arabinose resistance test with Salmonella typhimurium as a primary tool for carcinogen screening.以鼠伤寒沙门氏菌进行L-阿拉伯糖抗性试验作为致癌物筛选的主要手段。
Cancer Res. 1988 Feb 15;48(4):907-12.
7
In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.利用鼠伤寒沙门氏菌对化学致癌物及相关化合物进行体外诱变性试验。
J Natl Cancer Inst. 1979 Apr;62(4):893-9.
8
The mutagenicity of saccharin impurities. I. Detection of mutagenic activity.糖精杂质的致突变性。I. 致突变活性的检测。
J Environ Pathol Toxicol. 1978 Sep-Oct;1(1):139-46.
9
SOS chromotest results in a broader context: empirical relationships between genotoxic potency, mutagenic potency, and carcinogenic potency.SOS 显色试验结果的更广泛背景:遗传毒性效力、致突变效力和致癌效力之间的经验关系。
Environ Mol Mutagen. 1996;27(4):270-305. doi: 10.1002/(SICI)1098-2280(1996)27:4<270::AID-EM4>3.0.CO;2-H.
10
Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.诱变剂的致癌性:鼠伤寒沙门氏菌诱变试验对啮齿动物致癌性的预测能力。
Cancer Res. 1987 Mar 1;47(5):1287-96.

引用本文的文献

1
Procedures for screening chemicals for carcinogenicity.化学物质致癌性筛查程序。
Br J Ind Med. 1980 Feb;37(1):1-10. doi: 10.1136/oem.37.1.1.